ESTRO 38 - Programme Book & Exhibition Guide

08:45 > The role of radiotherapy in Hodgkin Lymphoma - results from the German Hodgkin Study Group (GHSG) Speaker: H.T. Eich (Germany)

SATURDAY 27 APRIL 2019

SP-0021

09:00 > State of the art for indolent lymphoma Speaker: J. Yahalom (USA)

SP-0022

09:15 > Aggressive Lymphoma (DLBCL); when does addition of RT make a difference? Speaker: G. Mikhaeel (United Kingdom) 09:30 > Aggressive Lymphoma (DLBCL) - when does addition of RT doesn’t make a difference? Speaker: U. Vitolo (Italy)

SP-0023

SP-0024

09:45 > Discussion

SYMPOSIUM Image guided adaptive brachytherapy (IGABT) for primary vaginal cancer in Europe and North America 08:45 - 10:00 | Brown 2 Vaginal cancer is a rare tumour that accounts for less than 3% of all gynaecological malignancies. The main treatment includes definitive radiotherapy with combined chemotherapy and brachytherapy (BT). Studies in BT of vaginal cancer are mainly small retrospective series that can be divided in older studies using 2-dimensional BT and more recent studies using 3-dimensional image guided adaptive brachytherapy (IGABT). During the session European and North American experiences in IGABT of vaginal cancer will be discussed. Furthermore, an adaptive target concept for IGABT in vaginal cancer based on clinical findings and imaging (MRI) will be introduced. Finally, differences in dose planning of IGABT in vaginal cancer among institutions will be discussed.

Chair: L.U. Fokdal (Denmark) Co-chair: C. Chargari (France)

08:45 > Evidence for image guided adaptive brachytherapy in primary vaginal cancer Speaker: H. Westerveld (The Netherlands)

SP-0025

SCIENTIFIC PROGRAMME | Programme and Exhibition Guide

78